Literature DB >> 11391655

FBN1 exon 2 splicing error in a patient with Marfan syndrome.

D Guo1, F K Tan, A Cantu, S E Plon, D M Milewicz.   

Abstract

Mutations in FBN1 cause the autosomal dominant condition, Marfan syndrome. A single-base mutation that results in a skipping of exon 2 of FBN1 was found in a Marfan patient. By sequencing this proband's entire FBN1 gene and comparing the mutated DNA sequence with proband's unaffected family numbers, we confirmed this alteration was the causative mutation. The skipping of exon 2 creates a frameshift and premature termination codon, and forms a truncated fibrillin-1 composed only of 55 amino acids of N-terminus plus 45 nonsense amino acids. The mRNA transcription levels of the mutated FBN1 allele and the deposition of fibrillin-1 into extracellular matrix in fibroblast cells culture were assessed. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11391655     DOI: 10.1002/1096-8628(20010615)101:2<130::aid-ajmg1333>3.0.co;2-v

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  10 in total

Review 1.  FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders.

Authors:  Lynn Y Sakai; Douglas R Keene; Marjolijn Renard; Julie De Backer
Journal:  Gene       Date:  2016-07-18       Impact factor: 3.688

Review 2.  The molecular genetics of Marfan syndrome and related disorders.

Authors:  P N Robinson; E Arteaga-Solis; C Baldock; G Collod-Béroud; P Booms; A De Paepe; H C Dietz; G Guo; P A Handford; D P Judge; C M Kielty; B Loeys; D M Milewicz; A Ney; F Ramirez; D P Reinhardt; K Tiedemann; P Whiteman; M Godfrey
Journal:  J Med Genet       Date:  2006-03-29       Impact factor: 6.318

3.  Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome.

Authors:  Daniel P Judge; Nancy J Biery; Douglas R Keene; Jessica Geubtner; Loretha Myers; David L Huso; Lynn Y Sakai; Harry C Dietz
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

4.  Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with familial dysautonomia.

Authors:  Math P Cuajungco; Maire Leyne; James Mull; Sandra P Gill; Weining Lu; David Zagzag; Felicia B Axelrod; Channa Maayan; James F Gusella; Susan A Slaugenhaupt
Journal:  Am J Hum Genet       Date:  2003-02-06       Impact factor: 11.025

5.  Tocotrienol Treatment in Familial Dysautonomia: Open-Label Pilot Study.

Authors:  David Cheishvili; Channa Maayan; Naama Holzer; Jeanna Tsenter; Elad Lax; Sophie Petropoulos; Aharon Razin
Journal:  J Mol Neurosci       Date:  2016-04-30       Impact factor: 3.444

6.  An FBN1 pseudoexon mutation in a patient with Marfan syndrome: confirmation of cryptic mutations leading to disease.

Authors:  Dong-Chuan Guo; Prateek Gupta; Van Tran-Fadulu; Tera V Guidry; Magalie S Leduc; Frederick V Schaefer; Dianna M Milewicz
Journal:  J Hum Genet       Date:  2008-09-17       Impact factor: 3.172

7.  Premature termination mutations in FBN1: distinct effects on differential allelic expression and on protein and clinical phenotypes.

Authors:  Iris Schrijver; Wanguo Liu; Raanan Odom; Thomas Brenn; Peter Oefner; Heinz Furthmayr; Uta Francke
Journal:  Am J Hum Genet       Date:  2002-06-14       Impact factor: 11.025

8.  Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic events.

Authors:  Linnea M Baudhuin; Katrina E Kotzer; Susan A Lagerstedt
Journal:  Genet Med       Date:  2014-08-07       Impact factor: 8.822

9.  Qualitative and quantitative analysis of FBN1 mRNA from 16 patients with Marfan Syndrome.

Authors:  Lena Tjeldhorn; Silja Svanstrøm Amundsen; Tuva Barøy; Svend Rand-Hendriksen; Odd Geiran; Eirik Frengen; Benedicte Paus
Journal:  BMC Med Genet       Date:  2015-12-18       Impact factor: 2.103

10.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals.

Authors:  François-Olivier Desmet; Dalil Hamroun; Marine Lalande; Gwenaëlle Collod-Béroud; Mireille Claustres; Christophe Béroud
Journal:  Nucleic Acids Res       Date:  2009-04-01       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.